• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明尼苏达州儿童中 Epstein-Barr 病毒感染的年龄特异性流行率:种族/民族和家庭环境的影响。

Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment.

机构信息

Department of Pediatrics, HealthPartners, Bloomington.

Department of Laboratory Medicine and Pathology, University of Minnesota Medical School.

出版信息

Clin Infect Dis. 2014 Aug 15;59(4):501-8. doi: 10.1093/cid/ciu342. Epub 2014 May 11.

DOI:10.1093/cid/ciu342
PMID:24820696
Abstract

BACKGROUND

Primary Epstein-Barr virus (EBV) infection affects the host differently according to when in life it is acquired. Understanding risk factors for infection could be important for disease prevention, and the age-specific prevalence of infection must be known to optimize use of a prophylactic vaccine.

METHODS

Children 18 months to 19.9 years of age who had blood drawn for medical indications during an outpatient visit were eligible. Sera were tested for immunoglobulin G antibodies against EBV viral capsid antigen by enzyme immunoassay. Family demographic and socioeconomic data were obtained via scripted telephone questionnaires.

RESULTS

Consent was given for 876 of 914 (96%) subjects approached. Sera were available for 782 of 876 (89%) subjects and demographic/socioeconomic data obtained for 705 (90%) of them. Antibody prevalence, adjusted for age and sex, was as follows: non-Hispanic blacks, 74%; Asians, 62%, multiracial children, 54%; Hispanics, 50%; and non-Hispanic whites, 26%. The pattern of increases in antibody prevalence with age differed significantly by race/ethnicity, and was most divergent in the 2 youngest age groups. Adjusted EBV antibody prevalence decreased with greater household education among non-Hispanic whites, but was not associated with any other socioeconomic factor. In 42 of 51 (82%) families with >1 child in the study, the siblings' EBV antibody status was concordant (bootstrap P < .001).

CONCLUSIONS

Racial/ethnic differences in EBV antibody prevalence and concordance of antibody status among siblings prompt us to speculate that both genetics and family environment contribute to acquisition of EBV infection. The ideal age to give a prophylactic vaccine may differ according to race/ethnicity.

摘要

背景

原发性 EBV(Epstein-Barr virus,EBV)感染根据其在生命中的感染时间而对宿主产生不同的影响。了解感染的危险因素对于疾病预防可能很重要,并且必须了解感染的年龄特异性患病率,以优化预防性疫苗的使用。

方法

在门诊就诊期间因医疗原因抽取血液的 18 个月至 19.9 岁的儿童符合条件。通过酶免疫测定法检测针对 EBV 衣壳抗原的 IgG 抗体。通过脚本电话问卷获得家庭人口统计学和社会经济数据。

结果

在 914 名被接触的对象中,876 名(96%)同意参加。在 876 名对象中,有 782 名(89%)获得了血清,对其中 705 名(90%)进行了人口统计学/社会经济数据的收集。经年龄和性别调整后的抗体流行率如下:非西班牙裔黑人,74%;亚洲人,62%,多种族儿童,54%;西班牙裔,50%;和非西班牙裔白人,26%。不同种族/族裔的抗体流行率随年龄增加的模式差异显著,在年龄最小的两个年龄组中差异最大。在非西班牙裔白人中,家庭受教育程度越高,调整后的 EBV 抗体流行率越低,但与任何其他社会经济因素无关。在研究中,42 个(82%)有多个孩子的家庭中,兄弟姐妹的 EBV 抗体状态是一致的(bootstrap P <.001)。

结论

EBV 抗体流行率的种族/族裔差异以及兄弟姐妹之间抗体状态的一致性促使我们推测,遗传和家庭环境都有助于 EBV 感染的发生。理想的预防性疫苗接种年龄可能因种族/族裔而异。

相似文献

1
Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment.明尼苏达州儿童中 Epstein-Barr 病毒感染的年龄特异性流行率:种族/民族和家庭环境的影响。
Clin Infect Dis. 2014 Aug 15;59(4):501-8. doi: 10.1093/cid/ciu342. Epub 2014 May 11.
2
Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition.美国 6-19 岁人群中 Epstein-Barr 病毒感染的年龄特异性流行率及其影响获得感染的因素。
J Infect Dis. 2013 Oct 15;208(8):1286-93. doi: 10.1093/infdis/jit321. Epub 2013 Jul 18.
3
Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults.以色列青年男性中 EB 病毒和巨细胞病毒的血清流行病学研究。
Ann Epidemiol. 2012 Nov;22(11):783-8. doi: 10.1016/j.annepidem.2012.06.099. Epub 2012 Jul 24.
4
Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in Vitória, State of Espírito Santo, Brazil.巴西圣埃斯皮里图州维多利亚市健康儿童和青少年中爱泼斯坦-巴尔病毒抗体的流行情况。
Rev Soc Bras Med Trop. 2004 Sep-Oct;37(5):409-12. doi: 10.1590/s0037-86822004000500008. Epub 2004 Sep 3.
5
Prevalence of Epstein-Barr virus in Japan: trends and future prediction.日本爱泼斯坦-巴尔病毒的流行情况:趋势与未来预测。
Pathol Int. 2006 Mar;56(3):112-6. doi: 10.1111/j.1440-1827.2006.01936.x.
6
Coprevalence of Epstein-Barr Virus, Cytomegalovirus, and Herpes Simplex Virus Type-1 Antibodies Among United States Children and Factors Associated With Their Acquisition.美国儿童中EB病毒、巨细胞病毒和1型单纯疱疹病毒抗体的共同流行情况及其感染相关因素。
J Pediatric Infect Dis Soc. 2015 Dec;4(4):323-9. doi: 10.1093/jpids/piu076. Epub 2014 Jul 17.
7
High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.狼疮病情复发的成年患者中抗爱泼斯坦-巴尔病毒衣壳抗原免疫球蛋白A抗体的高流行率:病例对照研究
J Rheumatol. 2005 Jan;32(1):44-7.
8
Seroepidemiological study of Epstein-Barr virus infection in Bangladesh.孟加拉国爱泼斯坦-巴尔病毒感染的血清流行病学研究。
J Med Virol. 1996 Jan;48(1):17-21. doi: 10.1002/(SICI)1096-9071(199601)48:1<17::AID-JMV3>3.0.CO;2-O.
9
Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state.通过免疫荧光和免疫印迹法评估爱泼斯坦-巴尔病毒抗体、抗VCA亲和力,以评估爱泼斯坦-巴尔病毒免疫状态。
J Virol Methods. 2009 Aug;159(2):300-2. doi: 10.1016/j.jviromet.2009.04.009. Epub 2009 May 3.
10
Seroepidemiological Study of Epstein-Barr Virus in Different Population Groups in Croatia.克罗地亚不同人群中爱泼斯坦-巴尔病毒的血清流行病学研究。
Isr Med Assoc J. 2018 Feb;20(2):86-90.

引用本文的文献

1
Epstein-Barr Virus Detection in Lymphoproliferative Disorders: Epidemiological Characterization in Western Mexico.淋巴增生性疾病中爱泼斯坦-巴尔病毒的检测:墨西哥西部的流行病学特征
Infect Dis Rep. 2025 Aug 14;17(4):100. doi: 10.3390/idr17040100.
2
Molecular epidemiology and clinical patterns of Epstein-Barr virus infection in Southwestern Saudi Arabia: a 2020-2023 retrospective study.沙特阿拉伯西南部地区爱泼斯坦-巴尔病毒感染的分子流行病学及临床特征:一项2020 - 2023年的回顾性研究
BMC Infect Dis. 2025 Aug 25;25(1):1066. doi: 10.1186/s12879-025-11407-2.
3
Equity in protection: bridging global data gaps for an EBV vaccine-a systematic review and meta-analysis.
保护公平性:弥合全球EBV疫苗数据差距——一项系统评价与荟萃分析
BMJ Glob Health. 2025 Aug 14;10(8):e015534. doi: 10.1136/bmjgh-2024-015534.
4
Epstein-Barr virus (EBV) serology and its impact on oral human papillomavirus (HPV) infection outcomes in children during early childhood.爱泼斯坦-巴尔病毒(EBV)血清学及其对幼儿期儿童口腔人乳头瘤病毒(HPV)感染结果的影响。
Microbiol Spectr. 2025 Sep 2;13(9):e0007125. doi: 10.1128/spectrum.00071-25. Epub 2025 Aug 1.
5
Epstein-Barr Virus Seroprevalence in Thailand: A Temporal and Global Perspective with Health Care and Economic Correlations.泰国的爱泼斯坦-巴尔病毒血清流行率:从时间和全球视角看与医疗保健及经济的相关性
Am J Trop Med Hyg. 2025 Apr 29;113(1):86-93. doi: 10.4269/ajtmh.24-0857. Print 2025 Jul 2.
6
Racial disparities in cancer risk among MSM with HIV in the United States.美国感染艾滋病毒的男男性行为者在癌症风险方面的种族差异。
AIDS. 2025 May 1;39(6):728-736. doi: 10.1097/QAD.0000000000004125. Epub 2025 Apr 3.
7
Population-Based Incidence of Infectious Mononucleosis and Related Hospitalizations: 2010 Through 2021.2010年至2021年基于人群的传染性单核细胞增多症发病率及相关住院情况
Mayo Clin Proc. 2025 Jun;100(6):982-992. doi: 10.1016/j.mayocp.2024.09.017. Epub 2025 Mar 7.
8
The Functional Interaction Between Epstein-Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma.爱泼斯坦-巴尔病毒与MYC在伯基特淋巴瘤发病机制中的功能相互作用
Cancers (Basel). 2024 Dec 18;16(24):4212. doi: 10.3390/cancers16244212.
9
Antimicrobials use and infection hospital contacts as proxies of infection exposure at ages 0-2 years and risk of infectious mononucleosis.抗生素使用和医院感染接触可作为 0-2 岁儿童感染暴露的替代指标,与传染性单核细胞增多症的风险相关。
Sci Rep. 2023 Dec 1;13(1):21251. doi: 10.1038/s41598-023-48509-3.
10
IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease.IgA 肾病:EB 病毒感染对免疫发病机制和疾病种族发生率的多效影响。
Front Immunol. 2023 Feb 7;14:1085922. doi: 10.3389/fimmu.2023.1085922. eCollection 2023.